{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T07:27:41Z","timestamp":1779089261131,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP15K18902"],"award-info":[{"award-number":["JP15K18902"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20K06953"],"award-info":[{"award-number":["JP20K06953"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.bmc.2025.118086","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T17:06:07Z","timestamp":1738083967000},"page":"118086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Development of novel BACE1 inhibitors with a hydroxyproline-derived N-amidinopyrrolidine scaffold"],"prefix":"10.1016","volume":"120","author":[{"given":"Kazuya","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinami","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misaki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rani","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaho","family":"Komurasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meguru","family":"Kuwano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayu","family":"Ikemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsuki","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunao","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Akaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2025.118086_b0005","unstructured":"World Health Organization. Web site. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia. Accessed October 12, 2024."},{"key":"10.1016\/j.bmc.2025.118086_b0010","doi-asserted-by":"crossref","unstructured":"GBD 2019 Dementia forecasting collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: An analysis for the Global Burden of Disease Study 2019. Lancet Public Health, 2022;7(2):e105-e125. https:\/\/doi.org\/10.1016\/s2468-2667(21)00249-8.","DOI":"10.1016\/S2468-2667(21)00249-8"},{"key":"10.1016\/j.bmc.2025.118086_b0015","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer\u2019s disease: Genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1016\/j.bmc.2025.118086_b0020","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer\u2019s disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2025.118086_b0025","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.286.5440.735","article-title":"\u03b2-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by the transmembrane aspartic protease BACE","volume":"286","author":"Vassar","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bmc.2025.118086_b0030","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/mcne.1999.0811","article-title":"Identification of a novel aspartic protease (Asp 2) as \u03b2-secretase","volume":"14","author":"Hussain","year":"1999","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.bmc.2025.118086_b0035","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1073\/pnas.97.4.1456","article-title":"Human aspartic protease memapsin 2 cleaves the \u03b2-secretase site of \u03b2-amyloid precursor protein","volume":"97","author":"Lin","year":"2000","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2025.118086_b0040","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1021\/jm101168r","article-title":"\u03b3-secretase modulators as potential disease modifying anti-Alzheimer\u2019s drugs","volume":"54","author":"Oehlrich","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118086_b0045","doi-asserted-by":"crossref","first-page":"7389","DOI":"10.1021\/acs.jmedchem.5b01960","article-title":"Gamma secretase modulators: New Alzheimer\u2019s drugs on the horizon?","volume":"59","author":"Bursavich","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118086_b0050","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1474-4422(13)70276-X","article-title":"Targeting the \u03b2 secretase BACE1 for Alzheimer\u2019s disease therapy","volume":"13","author":"Yan","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bmc.2025.118086_b0055","doi-asserted-by":"crossref","first-page":"6765","DOI":"10.1039\/C3CS60460H","article-title":"BACE1 (\u03b2-secretase) inhibitors for the treatment of Alzheimer\u2019s disease","volume":"43","author":"Ghosh","year":"2014","journal-title":"Chem Soc Rev."},{"key":"10.1016\/j.bmc.2025.118086_b0060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/molecules22010004","article-title":"Development and structural modification of BACE1 inhibitors","volume":"22","author":"Gu","year":"2017","journal-title":"Molecules."},{"key":"10.1016\/j.bmc.2025.118086_b0065","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.bmcl.2018.12.049","article-title":"New evolutions in the BACE1 inhibitor field from 2014 to 2018","volume":"29","author":"Hsiao","year":"2019","journal-title":"Bioorg Med Chem Lett."},{"key":"10.1016\/j.bmc.2025.118086_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103649","article-title":"Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands","volume":"97","author":"Iraji","year":"2020","journal-title":"Bioorg Chem."},{"key":"10.1016\/j.bmc.2025.118086_b0075","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.2174\/1570159X19666211201094031","article-title":"BACE1: A key regulator in Alzheimer\u2019s disease progression and current development of its inhibitors","volume":"20","author":"Patel","year":"2022","journal-title":"Curr Neuropharmacol."},{"key":"10.1016\/j.bmc.2025.118086_b0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12929-017-0355-7","article-title":"Drug candidates in clinical trials for Alzheimer\u2019s disease","volume":"24","author":"Hung","year":"2017","journal-title":"J Biomed Sci."},{"key":"10.1016\/j.bmc.2025.118086_b0085","doi-asserted-by":"crossref","first-page":"8823","DOI":"10.3390\/molecules27248823","article-title":"BACE1 inhibitors for Alzheimer\u2019s disease: The past, present and any future?","volume":"27","author":"Bazzari","year":"2022","journal-title":"Molecules."},{"key":"10.1016\/j.bmc.2025.118086_b0090","doi-asserted-by":"crossref","first-page":"10435","DOI":"10.1021\/acs.jmedchem.6b00307","article-title":"Discovery of the 3-imino-1,2,4-thiadiazinane 1,1-dioxide derivative verubecestat (MK-8931)\u2212A \u03b2-site amyloid precursor protein cleaving enzyme 1 inhibitor for the treatment of Alzheimer\u2019s disease","volume":"59","author":"Scott","year":"2016","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmc.2025.118086_b0095","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1706441","article-title":"Randomized trial of verubecestat for mild-to-moderate Alzheimer\u2019s disease","volume":"378","author":"Egan","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bmc.2025.118086_b0100","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.trci.2016.08.001","article-title":"Profiling the dynamics of CSF and plasma A\u03b2 reduction after treatment with JNJ-54861911, a potent oral BACE inhibitor","volume":"2","author":"Timmers","year":"2016","journal-title":"Alzheimers Dement (n y)."},{"key":"10.1016\/j.bmc.2025.118086_b0105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13195-018-0415-6","article-title":"Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer\u2019s disease: Randomized, double-blind, placebo-controlled study","volume":"10","author":"Timmers","year":"2018","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.bmc.2025.118086_b0110","unstructured":"Details of elenbecestat are given at the Alzforum. Web site. http:\/\/www.alzforum.org\/therapeutics\/elenbecestat. Accessed October 12, 2024."},{"key":"10.1016\/j.bmc.2025.118086_b0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bmc.2025.118086_b0120","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1016\/j.bmc.2011.03.056","article-title":"Evaluation of superior BACE1 cleavage sequences containing unnatural amino acids","volume":"19","author":"Kakizawa","year":"2011","journal-title":"Bioorg Med Chem."},{"key":"10.1016\/j.bmc.2025.118086_b0125","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1126\/science.1131943","article-title":"Fluorine in pharmaceuticals: Looking beyond intuition","volume":"317","author":"M\u00fcller","year":"2007","journal-title":"Science."},{"key":"10.1016\/j.bmc.2025.118086_b0130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/cmdc.200800321","article-title":"Assessing the bioisosterism of the trifluoromethyl group with a protease probe","volume":"4","author":"Jagodzinska","year":"2009","journal-title":"ChemMedChem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625000276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625000276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T21:12:15Z","timestamp":1740517935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625000276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":26,"alternative-id":["S0968089625000276"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118086","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of novel BACE1 inhibitors with a hydroxyproline-derived N-amidinopyrrolidine scaffold","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118086"}}